The lymphatic system: a therapeutic target for central nervous system disorders

被引:18
|
作者
Xu, Jia-Qi [1 ,2 ,3 ,4 ]
Liu, Qian-Qi [1 ,2 ,3 ,4 ]
Huang, Sheng-Yuan [5 ]
Duan, Chun-Yue [1 ,2 ,3 ,4 ]
Lu, Hong-Bin [2 ,3 ,4 ,6 ]
Cao, Yong [1 ,2 ,3 ,4 ]
Hu, Jian-Zhong [1 ,2 ,3 ,4 ]
机构
[1] Cent South Univ, Dept Spine Surg & Orthopaed, Xiangya Hosp, Changsha, Hunan Province, Peoples R China
[2] Key Lab Organ Injury Aging & Regenerat Med Hunan P, Changsha, Hunan Province, Peoples R China
[3] Mobile Hlth Minist Educ, China Mobile Joint Lab, Changsha, Hunan Province, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan Province, Peoples R China
[5] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Surg, Changsha, Hunan Province, Peoples R China
[6] Cent South Univ, Xiangya Hosp, Dept Sports Med, Changsha, Hunan Province, Peoples R China
基金
中国国家自然科学基金;
关键词
central nervous system; central nervous system injury; glymphatic system; lymphatic vessels; meninges; neurodegenerative disorders; neuroinflammatory diseases; vascular endothelial growth factor C; CEREBROSPINAL-FLUID; GLYMPHATIC PATHWAY; CERVICAL LYMPH; DURA-MATER; MENINGEAL LYMPHATICS; PERIVASCULAR SPACES; MOUSE MODEL; RAT-BRAIN; T-CELLS; IMPAIRMENT;
D O I
10.4103/1673-5374.355741
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The lymphatic vasculature forms an organized network that covers the whole body and is involved in fluid homeostasis, metabolite clearance, and immune surveillance. The recent identification of functional lymphatic vessels in the meninges of the brain and the spinal cord has provided novel insights into neurophysiology. They emerge as major pathways for fluid exchange. The abundance of immune cells in lymphatic vessels and meninges also suggests that lymphatic vessels are actively involved in neuroimmunity. The lymphatic system, through its role in the clearance of neurotoxic proteins, autoimmune cell infiltration, and the transmission of pro-inflammatory signals, participates in the pathogenesis of a variety of neurological disorders, including neurodegenerative and neuroinflammatory diseases and traumatic injury. Vascular endothelial growth factor C is the master regulator of lymphangiogenesis, a process that is critical for the maintenance of central nervous system homeostasis. In this review, we summarize current knowledge and recent advances relating to the anatomical features and immunological functions of the lymphatic system of the central nervous system and highlight its potential as a therapeutic target for neurological disorders and central nervous system repair.
引用
收藏
页码:1249 / 1256
页数:8
相关论文
共 50 条
  • [41] Central nervous system malformations and contributing disorders
    Yimenicioglu, Sevgi
    Yakut, Ayten
    Ekici, Arzu
    Yarar, Coskun
    Carman, Kursat Bora
    Kocak, Ozan
    Arslantas, Didem
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 18151 - 18159
  • [42] Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases
    Navarro-Mabarak, Cynthia
    Camacho-Carranza, Rafael
    Javier Espinosa-Aguirre, Jesus
    DRUG METABOLISM REVIEWS, 2018, 50 (02) : 95 - 108
  • [43] Hydrogels for central nervous system therapeutic strategies
    Russo, Teresa
    Tunesi, Marta
    Giordano, Carmen
    Gloria, Antonio
    Ambrosio, Luigi
    PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE, 2015, 229 (12) : 905 - 916
  • [44] Glutamate transporter-1 (GLT-1): a potential therapeutic target for the treatment of central nervous system diseases and disorders
    Abou-Gharbia, M.
    Blass, B.
    Childers, W.
    Ramanjulu, M.
    Melenski, E.
    DRUGS OF THE FUTURE, 2017, 42 (08) : 489 - 509
  • [45] Exploring the Therapeutic Potential of Selenium Nanoparticles in Central Nervous System Disorders: A Nanomedicine Approach
    Balaraju, Prajwal Chamanahalli
    Manchegowda, Jayanth Baburayanakoppal
    Kumar, Chandan
    Raghunathanaidu, Bharathi Doddla
    Hanumaiah, Ananth Gowda K. M. Doddi
    Lokesha, Varun Nagamangala
    Ahmed, Syed Sagheer
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (04) : 1025 - 1034
  • [46] C1q and central nervous system disorders
    Zhang, Wenjie
    Chen, Yuan
    Pei, Hui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes
    Mirzadeh, Zaman
    Faber, Chelsea L.
    Schwartz, Michael W.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 55 - 84
  • [48] [Central nervous system disorders diagnosed in dogs]
    Frade, Maria T. S.
    Ferreira, Jefferson S.
    Nascimento, Maria J. R.
    Aquino, Vitoria V. F.
    Macedo, Isabel L.
    Carneiro, Rosileide S.
    Souza, Almir P.
    Dantas, Antonio F. M.
    PESQUISA VETERINARIA BRASILEIRA, 2018, 38 (05): : 935 - 948
  • [49] Therapeutic indications for central nervous system cavernomas
    Chazal, J.
    Khalil, T.
    Sakka, L.
    NEUROCHIRURGIE, 2007, 53 (2-3) : 251 - 255
  • [50] A review for the pharmacological effect of lycopene in central nervous system disorders
    Chen, Dongjian
    Huang, Chao
    Chen, Zhuo
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 791 - 801